Corient Private Wealth LLC Purchases 11,650 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Corient Private Wealth LLC raised its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 331.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,163 shares of the company's stock after acquiring an additional 11,650 shares during the period. Corient Private Wealth LLC's holdings in Prestige Consumer Healthcare were worth $1,184,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in PBH. Kestra Investment Management LLC acquired a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at $27,000. GAMMA Investing LLC raised its position in Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after purchasing an additional 220 shares during the period. KBC Group NV boosted its position in shares of Prestige Consumer Healthcare by 28.3% in the fourth quarter. KBC Group NV now owns 2,048 shares of the company's stock worth $160,000 after buying an additional 452 shares during the period. Blue Trust Inc. grew its stake in shares of Prestige Consumer Healthcare by 24.8% in the fourth quarter. Blue Trust Inc. now owns 2,190 shares of the company's stock valued at $158,000 after buying an additional 435 shares in the last quarter. Finally, Longboard Asset Management LP acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter valued at about $201,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

PBH has been the subject of a number of research analyst reports. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research note on Thursday, December 19th. StockNews.com raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Tuesday, March 18th. Sidoti downgraded Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 target price on the stock. in a report on Monday, December 9th. Oppenheimer upped their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. Finally, Royal Bank of Canada lifted their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a report on Friday, March 21st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Remove Ads

Prestige Consumer Healthcare Stock Down 1.2 %

Shares of PBH traded down $1.03 during trading hours on Friday, hitting $85.01. 314,373 shares of the company were exchanged, compared to its average volume of 271,302. The company has a market cap of $4.21 billion, a PE ratio of 19.91, a PEG ratio of 2.69 and a beta of 0.46. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The firm's 50 day moving average is $83.30 and its 200-day moving average is $79.08. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.